A Majority of Adults Have Pre-Existing Antibody Reactivity to SARS-CoV-2: Study

A Majority of Adults Have Pre-Existing Antibody Reactivity to SARS-CoV-2: Study

Most adults examined in a recent study have pre-existing antibody reactivity to SARS-CoV-2, even if they haven’t had COVID-19. Interestingly, the research by Majdoubi, Michalski et al demonstrated the existence of these cross-reactive antibodies as far back as May 2020. From the abstract:

“Using a highly sensitive multiplex assay and positive/negative thresholds established in infants in whom maternal antibodies have waned, we determined that more than 90% of uninfected adults showed antibody reactivity against the spike protein, receptor-binding domain (RBD), N-terminal domain (NTD), or the nucleocapsid (N) protein from SARS-CoV-2.”

We conclude that most adults display preexisting antibody cross-reactivity against SARS-CoV-2, which further supports investigation of how this may impact the clinical severity of COVID-19 or SARS-CoV-2 vaccine responses.

Share on facebook
Share on twitter
Share on linkedin
Share on email

Related Posts